Investing.com - EDAP reported on Wednesday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
EDAP announced earnings per share of €-0.01 on revenue of €10.35M. Analysts polled by Investing.com anticipated EPS of €0.015 on revenue of €11.34M.
EDAP shares are up 19.54% from the beginning of the year and are trading at €6.180 , down-from-52-week-high.They are outperforming the Nasdaq which is up 16.71% from the start of the year.
EDAP follows other major Healthcare sector earnings this month
EDAP's report follows an earnings beat by Pfizer on Wednesday, July 28, 2021, who reported EPS of €1.07 on revenue of €18.98B, compared to forecasts EPS of €0.9705 on revenue of €18.71B.
Eli Lilly had missed expectations on Tuesday, August 3, 2021 with second quarter EPS of €1.87 on revenue of €6.74B, compared to forecast for EPS of €1.89 on revenue of €6.6B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar